Adjuvant treatment with tamoxifen. Informed consent and follow up in aTTom trial are inadequate.
作者信息
Cunningham H
出版信息
BMJ. 1996 Aug 24;313(7055):494. doi: 10.1136/bmj.313.7055.494.
Abstract
摘要
相似文献
1
Adjuvant treatment with tamoxifen. Informed consent and follow up in aTTom trial are inadequate.他莫昔芬辅助治疗。aTTom试验中的知情同意和随访不充分。
BMJ. 1996 Aug 24;313(7055):494. doi: 10.1136/bmj.313.7055.494.
2
The optimal duration of adjuvant tamoxifen treatment for breast cancer remains uncertain: randomize into aTTom.乳腺癌辅助他莫昔芬治疗的最佳持续时间仍不确定：随机分组进入aTTom试验。
Clin Oncol (R Coll Radiol). 1997;9(3):141-3. doi: 10.1016/s0936-6555(97)80067-2.
3
Tamoxifen beyond 5 years--patients' decisions regarding entry to the aTTom trial.他莫昔芬使用超过5年——患者关于参加aTTom试验的决定
Eur J Cancer. 2002 Sep;38(14):1857-9. doi: 10.1016/s0959-8049(02)00220-4.
4
Aromatase inhibitors in adjuvant therapy of breast cancer: before, instead of, or beyond tamoxifen.芳香化酶抑制剂在乳腺癌辅助治疗中的应用：在他莫昔芬之前、替代他莫昔芬，还是超越他莫昔芬
J Clin Oncol. 2005 Aug 1;23(22):4850-2. doi: 10.1200/JCO.2005.03.904. Epub 2005 Jul 11.
5
Tamoxifen and contralateral breast cancer.他莫昔芬与对侧乳腺癌
J Am Coll Surg. 1999 Jun;188(6):678-83. doi: 10.1016/s1072-7515(99)00057-5.
6
LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.促黄体生成素释放激素激动剂用于绝经前妇女早期乳腺癌的辅助治疗。
Cochrane Database Syst Rev. 2008 Oct 8(4):CD004562. doi: 10.1002/14651858.CD004562.pub3.
7
Re: Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.回复：来曲唑在他莫昔芬之后作为受体阳性乳腺癌延长辅助治疗的随机试验：加拿大国家癌症研究所临床试验组MA.17的最新研究结果
J Natl Cancer Inst. 2006 Aug 16;98(16):1162; author reply 1162-3. doi: 10.1093/jnci/djj323.
8
Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01).针对绝经后早期乳腺癌患者进行的他莫昔芬辅助治疗2年与5年对比的随机试验的12年死亡率结果（SITAM 01）
Cancer. 2006 Jul 1;107(1):215; author reply 215-6. doi: 10.1002/cncr.21960.
9
Tamoxifen for early breast cancer.他莫昔芬用于早期乳腺癌。
Cochrane Database Syst Rev. 2001(1):CD000486. doi: 10.1002/14651858.CD000486.
10
[Tamoxifen--"golden standard" in the treatment of patients with early breast cancer].他莫昔芬——早期乳腺癌患者治疗的“金标准”
Vopr Onkol. 2001;47(1):108-12.
本文引用的文献
1
Long term adjuvant therapy for primary breast cancer.原发性乳腺癌的长期辅助治疗。
BMJ. 1996 Feb 17;312(7028):389-90. doi: 10.1136/bmj.312.7028.389.
2
The EBCTCG overview of adjuvant therapy of breast cancer. What are the implications for future studies? Early Breast Cancer Trialists' Collaborative Group.早期乳腺癌试验者协作组：乳腺癌辅助治疗的EBCTCG综述。对未来研究有何启示？
Ann N Y Acad Sci. 1993 Nov 30;698:339-48. doi: 10.1111/j.1749-6632.1993.tb17224.x.
3
Staging of prostate cancer.前列腺癌的分期
Cancer. 1994 Jul 1;74(1):1-3. doi: 10.1002/1097-0142(19940701)74:1<1::aid-cncr2820740102>3.0.co;2-2.
Zotero 插件